التفاصيل البيبلوغرافية
العنوان: |
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer |
المؤلفون: |
Kunder, Ratika, Velyunskiy, Michelle, Dunne, Sara F., Cho, Byoung-Kyu, Kanojia, Deepak, Begg, Lauren, Orriols, Adrienne M., Fleming-Trujillo, Erica, Vadlamani, Pranathi, Vialichka, Alesia, Bolin, Rosemary, Perrino, Jessica N., Roth, Diane, Clutter, Matthew R., Zielinski-Mozny, Nicolette A., Goo, Young Ah, Cristofanilli, Massimo, Mendillo, Marc L., Vassilopoulos, Athanassios, Horiuchi, Dai |
المصدر: |
Cell Chemical Biology ; volume 29, issue 3, page 358-372.e5 ; ISSN 2451-9456 |
بيانات النشر: |
Elsevier BV |
سنة النشر: |
2022 |
المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: |
Clinical Biochemistry, Drug Discovery, Pharmacology, Molecular Biology, Molecular Medicine, Biochemistry |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1016/j.chembiol.2021.08.011 |
الإتاحة: |
https://doi.org/10.1016/j.chembiol.2021.08.011Test https://api.elsevier.com/content/article/PII:S2451945621004001?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2451945621004001?httpAccept=text/plainTest |
حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
رقم الانضمام: |
edsbas.A8E1F2CF |
قاعدة البيانات: |
BASE |